Sartorius has acquired ViroCyt, a Broomfield, Colorado-based start-up company with an automated platform for virus quantification, in a transaction valued at approximately $16 million. ViroCyt's customers are pharmaceutical and biopharmaceutical research and development laboratories, vaccine manufacturers, and academic institutes focused on virology.

ViroCyt's automated platform integrates instruments, software, and reagents for fast virus counting. The acquisition follows Sartorius' previous purchase of IntelliCyt, an Albuquerque, New Mexico-based manufacturer of integrated instrumentation, software, and reagent solutions for cell screening, in June 2016 for $90 million.

Source: Sartorius